{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:52:06Z","timestamp":1792396326778,"version":"4.4.0"},"reference-count":45,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA229535"],"award-info":[{"award-number":["R01CA229535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-StG-637830"],"award-info":[{"award-number":["ERC-StG-637830"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Platinum-based chemotherapy remains a mainstay treatment for the management of advanced non-small cell lung cancer. A key cellular factor that contributes to sensitivity to platinums is the 5\u2032-3\u2032 structure-specific endonuclease excision repair cross-complementation group 1 (ERCC1)\/ xeroderma pigmentosum group F (XPF). ERCC1\/XPF is critical for the repair of platinum-induced DNA damage and has been the subject of intense research efforts to identify small molecule inhibitors of its nuclease activity for the purpose of enhancing patient response to platinum-based chemotherapy. As an alternative to small molecule inhibitors, small interfering RNA (siRNA) has often been described to be more efficient in interrupting protein\u2013protein interactions. The goal of this study was therefore to determine whether biocompatible nanoparticles consisting of an amphiphilic triblock copolymer (polyethylenimine-polycaprolactone-polyethylene glycol (PEI-PCL-PEG)) and carrying siRNA targeted to ERCC1 and XPF made by microfluidic assembly are capable of efficient gene silencing and able to sensitize lung cancer cells to cisplatin. First, we show that our PEI-PCL-PEG micelleplexes carrying ERCC1 and XPF siRNA efficiently knocked down ERCC1\/XPF protein expression to the same extent as the standard siRNA transfection reagent, Lipofectamine. Second, we show that our siRNA-carrying nanoparticles enhanced platinum sensitivity in a p53 wildtype model of non-small cell lung cancer in vitro. Our results suggest that nanoparticle-mediated targeting of ERCC1\/XPF is feasible and could represent a novel therapeutic strategy for targeting ERCC1\/XPF in vivo.<\/jats:p>","DOI":"10.3390\/molecules25081994","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T01:24:18Z","timestamp":1588123458000},"page":"1994","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8148-9316","authenticated-orcid":false,"given":"Daniel P.","family":"Feldmann","sequence":"first","affiliation":[{"name":"Department of Oncology, School of Medicine and Barbara Ann Karmanos Institute, Wayne State University, Detroit, MI 48201, USA"},{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Heyza","sequence":"additional","affiliation":[{"name":"Department of Oncology, School of Medicine and Barbara Ann Karmanos Institute, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph M.","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, 81377 M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Patrick","sequence":"additional","affiliation":[{"name":"Department of Oncology, School of Medicine and Barbara Ann Karmanos Institute, Wayne State University, Detroit, MI 48201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-3916","authenticated-orcid":false,"given":"Olivia M.","family":"Merkel","sequence":"additional","affiliation":[{"name":"Department of Oncology, School of Medicine and Barbara Ann Karmanos Institute, Wayne State University, Detroit, MI 48201, USA"},{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, Wayne State University, Detroit, MI 48201, USA"},{"name":"Department of Pharmacy, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen, 81377 M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"ref_1","unstructured":"(2020, February 10). Cancer Stat Facts: Lung and Bronchus Cancer, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/lungb.html."},{"key":"ref_2","unstructured":"Kumar, V., Abbas, A.K., Fausto, N., and Mitchell, R.N. (2012). Robbins Basic Pathology, Elsevier Health Sciences."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dnarep.2010.03.010","article-title":"Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells","volume":"9","author":"Arora","year":"2010","journal-title":"DNA Repair"},{"key":"ref_6","first-page":"959","article-title":"Excision repair cross complementing-group 1: Gene expression and platinum resistance","volume":"14","author":"Altaha","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"ref_7","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer","volume":"8","author":"Lord","year":"2002","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-11-0790","article-title":"Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC","volume":"17","author":"Friboulet","year":"2011","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/jnci\/84.19.1512","article-title":"ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients","volume":"84","author":"Dabholkar","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI117388","article-title":"Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy","volume":"94","author":"Dabholkar","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-04-1387","article-title":"High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer","volume":"11","author":"Joshi","year":"2005","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-05-0042","article-title":"Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma","volume":"11","author":"Langer","year":"2005","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_14","first-page":"1123","article-title":"Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissues","volume":"7","author":"Reed","year":"2000","journal-title":"Oncol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2001.19.23.4298","article-title":"ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy","volume":"19","author":"Shirota","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1158\/1078-0432.CCR-18-3094","article-title":"Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer","volume":"25","author":"Heyza","year":"2019","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu10111644","article-title":"Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells","volume":"10","author":"Heyza","year":"2018","journal-title":"Nutrients"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"75104","DOI":"10.18632\/oncotarget.12072","article-title":"Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells","volume":"7","author":"Arora","year":"2016","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1016\/j.bmcl.2015.08.024","article-title":"N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF","volume":"25","author":"Chapman","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.bmcl.2015.08.031","article-title":"Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF","volume":"25","author":"Chapman","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.dnarep.2015.04.002","article-title":"Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance","volume":"31","author":"McNeil","year":"2015","journal-title":"DNA Repair"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/cbdd.13660","article-title":"Computer-Aided Drug Design of Small Molecule Inhibitors of the ERCC1-XPF Protein-Protein Interaction","volume":"95","author":"Gentile","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/mt.2011.263","article-title":"Progress toward in vivo use of siRNAs-II","volume":"20","author":"Rettig","year":"2012","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_25","first-page":"49","article-title":"Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran","volume":"24","author":"Brandao","year":"2019","journal-title":"Mol. Diagn. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40291-019-00438-6","article-title":"Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran","volume":"24","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: Advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bono, N., Ponti, F., Mantovani, D., and Candiani, G. (2020). Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020183"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jconrel.2020.02.032","article-title":"Small interfering RNA from the lab discovery to patients\u2019 recovery","volume":"321","author":"Caillaud","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2006.03.007","article-title":"Current status of polymeric gene delivery systems","volume":"58","author":"Park","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2011.04.017","article-title":"Biophysical characterization of hyper-branched polyethylenimine-graft-polycaprolactone-block-mono-methoxyl-poly(ethylene glycol) copolymers (hy-PEI-PCL-mPEG) for siRNA delivery","volume":"153","author":"Liu","year":"2011","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_35","first-page":"257","article-title":"Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors","volume":"22","author":"Essex","year":"2015","journal-title":"Gene"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/mp900107v","article-title":"Nonviral siRNA delivery to the lung: Investigation of PEG-PEI polyplexes and their in vivo performance","volume":"6","author":"Merkel","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_37","first-page":"98","article-title":"Characterization of poly (2-hydroxyethyl methacrylate) scaffolds for tissue engineering","volume":"2010","author":"Trinh","year":"2008","journal-title":"J. Undergrad. Res. Bioeng."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"224001","DOI":"10.1088\/1361-6528\/aa6d15","article-title":"The impact of microfluidic mixing of triblock micelleplexes on in vitro\/in vivo gene silencing and intracellular trafficking","volume":"28","author":"Feldmann","year":"2017","journal-title":"Nanotechnology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acs.biomac.5b01189","article-title":"Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance","volume":"17","author":"Jones","year":"2016","journal-title":"Biomacromolecules"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1016\/j.biomaterials.2012.05.055","article-title":"Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers","volume":"33","author":"Zheng","year":"2012","journal-title":"Biomaterials"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acs.molpharmaceut.5b00575","article-title":"Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol)","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jddst.2018.12.009","article-title":"Microfluidic manufacturing improves polydispersity of multicomponent polymeric nanoparticles","volume":"49","author":"Abstiens","year":"2019","journal-title":"J. Drug Deliv. Sci. Tec."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7717\/peerj-matsci.1","article-title":"A microfluidic approach for sequential assembly of siRNA polyplexes with a defined structure-activity relationship","volume":"1","author":"Loy","year":"2019","journal-title":"PeerJ Mater. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1126\/science.1066238","article-title":"Chaotic Mixer for Microchannels","volume":"295","author":"Abraham","year":"2002","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21101314","article-title":"Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery","volume":"21","author":"Li","year":"2016","journal-title":"Molecules"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/8\/1994\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:09:12Z","timestamp":1760364552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/8\/1994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["molecules25081994"],"URL":"https:\/\/doi.org\/10.3390\/molecules25081994","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}